ESR1 and neoplasm: To answer these queries, we took into account patient clinical-pathological factors, such as expression of progesterone receptors (PR) and ERα in cancer tissue, disease stage, lymph node metastasis, histological tumor type, presence or absence of menstrual cycle, applied neoadjuvant chemotherapy, age.